Background: Several epidemiological studies have been carried to identify the risk factors for developing breast cancer. The aim of this study was to evaluate the risk factors associated with breast cancer in different age groups in the Moroccan women and to determine susceptible and protective factors. Methods: This was a case control study including 400 women with breast cancer and 400 controls of the National Institute of Oncology Sidi Mohamed Ben Abdallah, Rabat, Morocco from 2008 to 2010. These women were interviewed for epidemiological information and risk factor for breast cancer. Results: Early age at menarche, late menopause, oral contraceptive and family history with first degree were positively associated with breast cancer in all the series and in the age group between 22 and 34 years. In the age group between 44 and 34 years, a risk of breast cancer was associated only with a family history of breast cancer. In the age group of 45 years or older, the factors which seem to influence a breast cancer are: late menopause, oral contraceptive and family history in the first degree. In contrast, early childbearing, multiparity and lactation were negatively associated with breast cancer. Conclusion: This study is rather in favour of positive association between hormonal factors and breast cancer, and confirms the protective role of multiparity and lactation.
Breast cancer occupies the first place in women because of its high rates of incidence and mortality [
The National Institute of Health and Medical Research estimates that the worldwide incidence of breast cancer has nearly doubled between 1980 and 2005, from 56.8 to 101.5 per 100,000 women mainly in developed countries like West Europe and North America.
In Morocco, breast cancer is the leading type of cancer in women. It is one of the most important public health problems, because the diagnosis is often delayed and the management is difficult and expensive. According to the population register of the Casablanca city, the annual national cancer incidence is estimated at 35,000 new cancer cases a year of which only 12,000 are supported.
However, this incidence tends to decrease in recent years due to a prevention tool that has so far proven effective in reducing mortality from breast cancer namely mammography screening and by stabilizing several risk factors (late age at first pregnancy, breastfeeding less...).
Breast cancer is a clinically heterogeneous and complex disease [
Therefore, the acquisition of basic knowledge on the mechanisms of oncogenesis related to these factors is an essential scientific direction for the improvement of current therapies and the development of new therapeutic approaches.
The aim of our study was to analyze the relationship between risk factors and breast cancer in different age groups of Moroccan women with breast cancer compared to healthy controls. Then it discussed the developments of these risk factors and biological basis of disease using data from recent publications.
We conducted a case-control study at the National Institute of Oncology Sidi Mohamed Ben Abdallah, Rabatin which we included a population of Moroccan women (collected between December 2008 and December 2010) we have divided into two groups, a group of women with breast cancer, and a group of breast cancer-free controls.
Recruitment of cases of breast cancer was based on a diagnosis of breast cancer confirmed by mammography, biopsy and/or surgery by specialists of the National Institute of Oncology. Women recruited and respondents must be of all ages and must be patients newly diagnosed as breast cancer, controls recruited at the same Institute within the framework of the cancer screening campaign organized by government authorities after having undergone a mammography that showed no signs of breast cancer.
To ensure maximum comparability between cases and controls and to ensure representative of the study population each case was matched with one control of the same age we did correspond to each case a witness of the same age. The subjects recruited for this study were aged between 22 and 75 years and were divided into three age groups (22 - 34 years, 35 - 44 years, 45 years and over).
We excluded from the study all women with chronic pathology associated, such as high blood pressure, diabetes and coronary heart disease, women who not within the age rank of 22 - 75 years and patients who were prescribed a treatment (chemotherapy, radiation therapy, hormone therapy).
The information was gathered from a baseline questionnaire that has been evaluated and tested by our research team, which was administered in a standardized manner to cases and controls. The information collected were for a certain number of risk factors implicated in mammary carcinogenesis and have been the subject of several epidemiological studies. The risk factors identified were: (1) age, (2) menopausal status, (3) age at menopause, (4) body mass index, (5) the age at menarche, (6) age at first full term pregnancy, (7) the number of children, (8) the duration of breastfeeding for each child, (9) oral contraceptives, (10) the hormone replacement therapy, (11) family history and (12) exposure to irradiation. To meet the objective of our study we formed three groups of women according to age: (i) resolve 22 - 34 years, (ii) resolve 35 - 44 years, (iii) slice 45 years and over and we tried to study in each of these groups a number of population risk factors implicated in mammary carcinogenesis and having made the subject of a number of epidemiological studies.
Risk factors collected in survey forms were carried out using SPSS 13.0 software (SPSS Inc., Chicago, IL, USA). The quantitative variables were expressed as mean value and standard deviation. The qualitative variables were expressed as percentages. The comparisons used were the student’s t-test, for quantitative variables, and the Pearson Chi2 test, for qualitative variables. The total group of Breast cancer women as well as different age subgroups was separately compared with the control group.
To identify susceptible and protective factors associated with breast cancer, comparisons between groups (women with breast cancer and breast cancer-free controls) were conducted using univariate logistic regression. The first level of significance was 5% and there was a confidence interval of 95%.
Respect for the anonymity and confidentiality of information was strictly adhered to. Informed consent was signed before the inclusion of women in the study.
Eight hundred women were included in this study and were divided into two populations: a population of 400 women with breast cancer and a population of 400 women who were breast cancer-free.
Results of the general settings of the population are presented in
The distribution of patients according to menopausal status shows that the frequency of menopausal women in the patient group is statistically higher than in the control group (64% versus 40%; p < 0.001). In addition, there was a significant difference in the number of children between the two groups (3.97 ± 2.17 births in controls vs 2.81 ± 2.20 births in patients; p < 0.001).
Moreover, the percentage of women whose term of contraception is more than 6 months was statistically higher in the patient population compared with controls (24.8% versus 13.5%; p < 0.001).
We compared the distribution of hormonal risk factors in women with breast cancer as compared with controls (
The overall frequency of women through menopause at a late age (over 55 years) was significantly higher among patients compared with control (24% vs 6%; p < 0.001). Interestingly, this frequency was significantly higher in the bracket above 45 years (41.4% vs 10.7%; p < 0.001). The frequency of women who took oral con- traceptives over 6 months was significantly higher in the patient group as compared with controls: in the overall series (24.8% versus 13.3%; p < 0.001) and in the range of greater than 45 years old (32.9% vs 17%; p < 0.001).
The reproductive factors of breast cancer by age subgroup are presented in
Control patients | Breast cancer patients | p-value | ||
---|---|---|---|---|
Characteristics | n = 400 (%) | n = 400 (%) | ||
Age group (mean ± SD years) | 45.51 ± 11.25 | 45.83 ± 11.05 | 0.685 | |
Age group (years) | ||||
22 - 34 | 64 (16) | 60 (15) | 0.843 | |
35 - 44 | 112 (28) | 108 (27) | ||
45 and over | 224 (56) | 232 (58) | ||
BMIb (Kg/m2) | 24.40 ± 3.22 | 28.35 ± 4.36 | <0.001 | |
Age at menarche (mean ± SD years) | 12.31 ± 1.39 | 11.98 ± 1.59 | 0.002 | |
Age at menopause (mean ± SD years) | 51.28 ± 2.74 | 50.22 ± 5.55 | 0.025 | |
Menaupausalstatus (%) | ||||
No | 240 (60) | 144 (36) | <0.001 | |
Yes | 160 (40) | 256 (64) | ||
Number of children (mean ± SD years) | 3.97 ± 2.17 | 2.81 ± 2.20 | <0.001 | |
Contraception (%) | ||||
Never | 96 (24.1) | 102 (25.5) | <0.001 | |
Lessthan six month | 250 (62.7) | 199 (49.9) | ||
Abovesix month | 54 (13.5) | 99 (24.8) | ||
Type of contraception (%) | ||||
Hormonal | 100 | 100 | ||
Barrier | 0 | 0 | ||
aValues are expressed as mean ± standard deviation or in count and percentage; bBMI: body mass index.
Characteristics | Age group 22 - 34 years | Age group 35 - 44 years | Age group 45 years and over | Overall series | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control patients n = 64 (%) | Breast cancer patients n = 60 (%) | p | Control patients n = 112 (%) | Breast cancer patients n = 108 (%) | p | Control patients n = 224 (%) | Breast cancer patients n = 232 (%) | p | Control patients n = 400 (%) | Breast cancer patients n = 400 (%) | p | |||
Ménarche | ||||||||||||||
< 12 years | 6 (9.4) | 19 (31.7) | 0 .02 | 21 (18.8) | 27 (25) | 0.262 | 52 (23.2) | 70 (30.2) | 0.093 | 79 (19.8) | 116 (29) | 0.002 | ||
≥12 years | 58 (90.6) | 41 (68.3) | 91 (81.3) | 81 (75) | 172 (76.8) | 162 (69.8) | 321 (80.3) | 284 (71) | ||||||
Ménopause | ||||||||||||||
<55 years | 0 (0) | 0 (0) | 3 (2.7) | 28 (25.9) | 133 (59.4) | 132 (56.9) | <0.001 | 136 (34) | 160 (40) | <0.001 | ||||
≥55 years | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 24 (10.7) | 96 (41.4) | 24 (6) | 96 (24) | ||||||
Contraceptifs oraux | ||||||||||||||
Never | 32 (50) | 44 (73.3) | 0.017 | 28 (25.2) | 32 (29.6) | 0.142 | 36 (16.1) | 25 (10.8) | <0.001 | 96 (24.1) | 102 (25.5) | <0.0001 | ||
<6 month | 30 (46.9) | 14 (23.2) | 70 (63.1) | 55 (50.9) | 150 (67) | 130 (66.3) | 250 (62.7) | 199 (49.9) | ||||||
≥6 month | 2 (3.1) | 2 (3.3) | 14 (12.5) | 21 (19.4) | 38 (17) | 76 (32.9) | 54 (13.5) | 99 (24.8) | ||||||
Hormone replacement therapy | ||||||||||||||
No | 64 (100) | 60 (100) | 112 (100) | 108 (100) | 216 (96.4) | 222 (95.7) | 0.685 | 392 (98) | 390 (19.75) | 0.634 | ||||
Yes | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 8 (3.6) | 10 (4.3) | 8 (2) | 10 (2.5) | ||||||
aValues are expressed as count and percentage.
Characteristics | Age group 22 - 34 years | Age group 35 - 44 years | Age group 45 years and over | Overall series | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Control patients n = 64 (%) | Breast cancer patients n = 60 (%) | p | Control patients n = 112 (%) | Breast cancer patients n = 108 (%) | p | Control patients n = 224 (%) | Breast cancer patients n = 232 (%) | p | Control patients n = 400 (%) | Breast cancer patients n = 400 (%) | p | |
Age at first full term pregnancy | ||||||||||||
No | 28 (43.8) | 45 (75) | 0.001 | 13 (11.6) | 30 (27.8) | <0.001 | 14 (6.3) | 28 (12.1) | <0.001 | 55 (13.8) | 103 (25.8) | <0.001 |
<30 years | 35 (54.7) | 13 (21.7) | 88 (78.6) | 44 (40.7) | 146 (65.2) | 76 (32.8) | 269 (67.3) | 133 (33.3) | ||||
≥30 years | 1 (1.6) | 2 (3.3) | 11 (9.8) | 34 (31.5) | 64 (28.6) | 128 (55.2) | 76 (19) | 164 (41) | ||||
Number of birth | ||||||||||||
Nulliparous | 28 (43.8) | 45 (75) | <0.001 | 12 (10.7) | 29 (26.9) | 0.002 | 13 (5.8) | 28 (12.1) | <0.001 | 53 (13.3) | 102 (25.5) | <0.001 |
1 to 2 | 23 (35.9) | 3 (5) | 10 (8.9) | 15 (13.9) | 0 (0) | 28 (12.1) | 33 (8.3) | 46 (11.5) | ||||
≥3 | 13 (20.3) | 12 (20) | 90 (80.4) | 64 (59.3) | 211 (94.2) | 176 (75.9) | 314 (78.5) | 252 (63) | ||||
Duration of breastfeeding | ||||||||||||
Never | 27 (42.2) | 46 (75) | 0.001 | 12 (10.7) | 32 (29.6) | 0.002 | 13 (5.8) | 30 (12.9) | 0.001 | 52 (13) | 107 (26.8) | <0.001 |
<6 month | 20 (31.3) | 3 (5) | 15 (13.4) | 14 (13) | 11 (4.9) | 27 (11.6) | 46 (11.5) | 44 (11) | ||||
≥6 month | 17 (26.6) | 12 (20) | 85 (75.9) | 62 (57.4) | 200 (89.3) | 175 (76.4) | 302 (75.5) | 249 (62.3) |
aValues are expressed as count and percentage.
As shown in
Results of the univariate logistic regression analysis are presented in
No significant association for breast cancer was found for hormone replacement, exposure to radiation and family history of breast cancer among second degree relatives.
In the present case-control study, we found several risk factors associated with breast cancer in a population of Moroccan women.
Firstly, women with early age of menarche are more prone to develop breast cancer than that of the last age of menarche. This association of the early age of menarche was significantly increased in the age subgroup between 22 and 34 years. These findings are in line with other studies [
In our population, late age at menopause was also found to be strongly linked to the presence of breast cancer. This association of late age at menopause is now largely supported by data from 51 epidemiological studies
Characteristics | Age group 22 - 34 years | Age group 35 - 44 years | Age group 45 years and over | Overall series | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Control patients n = 64 (%) | Breast cancer patients n = 60 (%) | p | Control patients n = 112 (%) | Breast cancer patients n = 108 (%) | p | Control patients n = 224 (%) | Breast cancer patients n = 232 (%) | p | Control patients n = 400 (%) | Breast cancer patients n = 400 (%) | p | |
Family history of breast cancer | ||||||||||||
No | 64 (100) | 56 (93.3) | 0.036 | 111 (99.1) | 102 (94.4) | 0.049 | 214 (95.5) | 185 (79.7) | <0.001 | 389 (97.3) | 343 (85.8) | <0.001 |
yes | 0 (0) | 4 (6.7) | 1 (0.9) | 6 (5.6) | 10 (4.5) | 47 (20.3) | 11 (2.8) | 57 (14.3) | ||||
Breast cancer among degree relatives | ||||||||||||
First degree | 0 (0) | 4 (6.7) | 0.036 | 0 (0) | 4 (3.7) | 0.098 | 3 (1.3) | 38 (16.4) | <0.001 | 3 (0.8) | 46 (11.5) | <0.001 |
Second degree | 0 (0) | 0 (0) | 1 (0.9) | 2 (1.9) | 7 (3.1) | 9 (3.9) | 8 (2) | 11 (2.8) | ||||
Exposure to irradiation | ||||||||||||
No | 63 (98.4) | 58 (96.7) | 0.521 | 107 (95.5) | 106 (98.1) | 0.270 | 218 (97.3) | 226 (97.4) | 0.951 | 388 (97) | 390 (97.5) | 0.665 |
Yes | 1 (1.6) | 2 (3.3) | 5 (4.5) | 2 (1.9) | 6 (2.7) | 6 (2.7) | 12 (3) | 10 (2.5) |
aValues are expressed as count and percentage.
Variables | ORa | 95% CI | p-value |
---|---|---|---|
Early age at menarche (<12 years) | 1.660 | 1.196 - 2.303 | 0.002 |
Late menopause (>55 years) | 2.360 | 1.911 - 2.914 | <0.001 |
Oral contraceptive (>6 years) | 1.252 | 1.014 - 1.547 | <0.001 |
Hormone replacement therapy | 1.256 | 0.491 - 3.217 | 0.634 |
Early childbearing (<30 years) | 0.229 | 0.163 - 0.323 | <0.001 |
Multiparity | 0.639 | 0.533 - 0.766 | <0.001 |
Lactation (>6 months) | 0.652 | 0.546 - 0.780 | <0.001 |
Family history of breast First degree | 11.146 | 2.535 - 49.005 | 0.001 |
Second degree | 0.641 | 0.255 - 1.613 | 0.345 |
Exposure to irradiation | 1.206 | 0.515 - 2.825 | 0.666 |
Odds ratio has been adjusted for age by univariate logistic regression. Significance threshold p < 0.05. aThese results were statistically significant; CI, confidence interval.
conducted by the collaborative group on hormonal factors in breast cancer [
One of the striking findings of the present study is that the risk of breast cancer is increased with oral contraceptives beyond 6 months. Indeed, the extensive use of contraceptives at a late age of reproductive life leads to a significant increase of developing breast cancer [
No association was observed between breast cancer and hormone replacement therapy. Conflicting results have been reported regarding this result.
Another important finding of the present study is that, early age at first pregnancy, multiparity and lactation were negatively associated with breast cancer suggested a protective effect of these factors for breast cancer. A protective role of the multiparity was consistent with the data in the literature that considers multiparity as a protective factor in breast carcinogenesis.
Despite the fact that in the five years following a transient increase in risk of breast cancer was associated with pregnancy in the five years following it [
The protective role of parity increases proportionately with the number of children and the early age at first birth. Thus, a first pregnancy before 30 years reduces the risk by 25% compared to a woman who has not had children [
In our study population, the frequency of women having their first full term pregnancy at an early age (below 30 years) was significantly decreased in the patient population compared to the control population. This decrease was also observed in a different age of our study population groups. Furthermore we found that early maternal age decreases by 23% the risk of breast cancer. Thus, women who have their first full term pregnancy before age 30 have an average risk of breast cancer decreased by 25% compared to nulliparous women [
-Lactation can suppress the occurrence and development of breast cancer by reducing estrogen levels and increased prolactin production, which are supposed to reduce cumulative exposure to estrogen in women [
-On the other hand it has been shown that the level of estrogen in the blood of lactating women gradually increases from the last birth and continues for several years before they reach the level that is recorded in nulliparous women [
-The pH of milk from the breasts of women who have not breastfed are significantly elevated compared to that from the breasts of women who have breastfed. During lactation, milk is acidic. The epithelial cells, in an alkaline environment, undergo alterations such as hyperplasia, atypia, and increased mitotic activity [
-Finally, the protective effect of breastfeeding to be due to its role in the shift of restoring ovulation (risk factor).
It was reported that a family history of breast cancer is strongly associated with breast cancer with a 2 - 3 fold increased risk, suggesting a stronger genetic component, and perhaps stronger associations with specific genes. In our work the risk arising from at last one family history of breast cancer among first degree relatives was elevated among all age groups of female patients compared with control women. This finding is in line with previous reports that found an association of family history with breast cancer. An epidemiological study [
There are a few limitations to our study: (a) the number of patients and controls enrolled is small and (b) it is conducted in a shorter period of time than is typical of studies which focus on the similar issues and (c) that it is single centre. However, our study possesses various strengths. One of its strengths lies in providing a platform to bring together more collaborators (clinicians and researchers) to carry out a more in-depth study.
Our study demonstrates a significant positive association between certain risk factors, in particular those related to hyperestrogenism (early age of menarche, age late menopause and use of oral contraceptives) and family history, and breast cancer in Moroccan women. Moreover, we found early age at first full-term pregnancy, multiparity and lactation as the most important protective factors in our population. Nevertheless, these results reinforce, suspicion hormonal factors, factors related to reproduction and genetic factors in the incidence of breast cancer in our country. Their knowledge is essential for public health actions.
Prospective studies in particular those related to environmental factors are needed to individualize the populations where the risk is greater and can be targeted for possible causes.
The authors declare that they have no competing interests.
AB reviewed the literature, data analysis and interpretation, and helped to draft the manuscript.
We thank all participants for taking part in this study.